Page last updated: 2024-10-23

berberine and Allergic Reaction

berberine has been researched along with Allergic Reaction in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Berberine (BBR) possesses many pharmacological characteristics including anti-inflammation, anti-allergy, anti-angiogenesis and anti-tumor."3.91Berberine suppresses IL-33-induced inflammatory responses in mast cells by inactivating NF-κB and p38 signaling. ( Fan, H; Li, W; Tao, W; Wang, Q; Wang, Z; Yin, N, 2019)
"Pretreatment with berberine prevented morphological changes in IgE-stimulated RBL-2H3 cells such as the recovery of an elongated shape."1.51Berberine suppresses mast cell-mediated allergic responses via regulating FcɛRI-mediated and MAPK signaling. ( Fu, M; Fu, S; Hong, T; Ni, S; Wang, D, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, W1
Yin, N1
Tao, W1
Wang, Q1
Fan, H1
Wang, Z1
Fu, S1
Ni, S1
Wang, D1
Fu, M1
Hong, T1

Other Studies

2 other studies available for berberine and Allergic Reaction

ArticleYear
Berberine suppresses IL-33-induced inflammatory responses in mast cells by inactivating NF-κB and p38 signaling.
    International immunopharmacology, 2019, Volume: 66

    Topics: Animals; Anti-Inflammatory Agents; Berberine; Cells, Cultured; Cytokines; Humans; Hypersensitivity;

2019
Berberine suppresses mast cell-mediated allergic responses via regulating FcɛRI-mediated and MAPK signaling.
    International immunopharmacology, 2019, Volume: 71

    Topics: Animals; Anti-Allergic Agents; Berberine; beta-N-Acetylhexosaminidases; Cell Degranulation; Cell Lin

2019